AMETEK, Inc. (NYSE:AME) Shares Bought by Flossbach Von Storch SE

Flossbach Von Storch SE raised its holdings in AMETEK, Inc. (NYSE:AMEFree Report) by 2.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 3,724,352 shares of the technology company’s stock after buying an additional 91,287 shares during the period. AMETEK makes up about 2.7% of Flossbach Von Storch SE’s portfolio, making the stock its 17th biggest holding. Flossbach Von Storch SE’s holdings in AMETEK were worth $671,352,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of AMETEK by 4.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,450 shares of the technology company’s stock valued at $261,000 after purchasing an additional 63 shares in the last quarter. AlphaMark Advisors LLC grew its holdings in AMETEK by 2.1% during the fourth quarter. AlphaMark Advisors LLC now owns 3,348 shares of the technology company’s stock valued at $604,000 after purchasing an additional 70 shares during the last quarter. Geneos Wealth Management Inc. grew its holdings in AMETEK by 42.9% during the fourth quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock valued at $42,000 after purchasing an additional 70 shares during the last quarter. Quotient Wealth Partners LLC boosted its position in shares of AMETEK by 3.9% in the fourth quarter. Quotient Wealth Partners LLC now owns 1,843 shares of the technology company’s stock valued at $332,000 after acquiring an additional 70 shares during the period. Finally, Wallace Advisory Group LLC lifted its position in AMETEK by 5.8% in the fourth quarter. Wallace Advisory Group LLC now owns 1,371 shares of the technology company’s stock worth $235,000 after purchasing an additional 75 shares during the period. 87.43% of the stock is owned by institutional investors and hedge funds.

AMETEK Price Performance

AMETEK stock opened at $188.82 on Thursday. AMETEK, Inc. has a 12 month low of $149.03 and a 12 month high of $198.33. The company has a current ratio of 1.24, a quick ratio of 0.75 and a debt-to-equity ratio of 0.15. The business’s 50 day simple moving average is $182.97 and its 200 day simple moving average is $177.69. The company has a market cap of $43.68 billion, a price-to-earnings ratio of 31.84, a PEG ratio of 2.69 and a beta of 1.16.

AMETEK (NYSE:AMEGet Free Report) last released its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.87 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.02. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.82 billion. AMETEK had a net margin of 19.83% and a return on equity of 16.94%. The business’s quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.68 earnings per share. Sell-side analysts forecast that AMETEK, Inc. will post 7.15 EPS for the current year.

AMETEK Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be issued a dividend of $0.31 per share. This is a positive change from AMETEK’s previous quarterly dividend of $0.28. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Friday, March 14th. AMETEK’s dividend payout ratio is currently 18.89%.

AMETEK announced that its Board of Directors has initiated a share repurchase plan on Friday, February 7th that authorizes the company to repurchase $1.25 billion in outstanding shares. This repurchase authorization authorizes the technology company to purchase up to 2.9% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Analyst Upgrades and Downgrades

AME has been the topic of several recent analyst reports. Robert W. Baird reduced their target price on shares of AMETEK from $200.00 to $197.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. BNP Paribas upgraded shares of AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 target price on the stock in a research report on Thursday, January 16th. Bank of America raised AMETEK from a “neutral” rating to a “buy” rating and upped their price target for the company from $195.00 to $225.00 in a research note on Monday, December 16th. StockNews.com raised AMETEK from a “hold” rating to a “buy” rating in a research note on Thursday, February 13th. Finally, Truist Financial increased their target price on AMETEK from $221.00 to $222.00 and gave the stock a “buy” rating in a research note on Thursday, January 16th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $204.67.

Check Out Our Latest Stock Report on AMETEK

Insider Transactions at AMETEK

In other AMETEK news, insider Emanuela Speranza sold 6,747 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $195.90, for a total transaction of $1,321,737.30. Following the completion of the transaction, the insider now owns 30,460 shares of the company’s stock, valued at approximately $5,967,114. This trade represents a 18.13 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Tony J. Ciampitti sold 16,210 shares of the firm’s stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $197.01, for a total transaction of $3,193,532.10. Following the sale, the insider now directly owns 49,490 shares of the company’s stock, valued at $9,750,024.90. This trade represents a 24.67 % decrease in their position. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by company insiders.

AMETEK Company Profile

(Free Report)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Featured Stories

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.